价格

Approvals/FDA/Paclitaxel protein-bound particles for injectable suspension (albumin-bound)

Approved

HUMAN PRESCRIPTION DRUG LABEL

1f7ae12ea6b2131f

Paclitaxel protein-bound particles for injectable suspension (albumin-bound)

Apotex Corp.🇺🇸 United States

FDA Page

Effective Date: Apr 1, 2022
Approval ID: 0ab36ac8-0536-4677-b7d0-0d5f9561f76f
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND) safely and effectively. See full prescribing information for PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND). PACLITAXEL protein-bound particles for injectable suspension (albumin-bound), for intravenous useInitial U.S. Approval: 2005

Quick Stats

Total Products1

Labelers2

Label Sections24

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.